Skip to content

Author

Mirza R. Baig

We have 10 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Sirtuin 1-microRNA regulatory networks in liver diseases: Mechanistic convergence, cellular senescence, and translational implications.

Metabolic dysfunction-associated steatotic liver disease, hepatotoxicity, liver fibrosis, and hepatocellular carcinoma are stages of chronic liver injury that occur in the setting of complex interactions of the various factors, including metabolic dysregulation, inflammation, oxidative stress, and cellular senescence....

Amr A. El-Sehrawy, Safa H. Radhie, Mirza R. Baig et al. · 0 citations
Review Sep 2026

HTLV-1 and ATL: Decoding Molecular Pathogenesis for Next-Generation Therapies.

Adult T-cell leukemia/lymphoma (ATL) is an aggressive T-lymphocyte malignancy arising as a late consequence of human T-cell leukemia virus type 1 (HTLV-1) infection. Despite decades of research, ATL remains characterized by a dismal prognosis and high relapse rates, representing a significant clinical challenge. This r...

Mina Mohammad-rezaei, Zahra Shafaghat, Mina Noroozbeygi et al. · 0 citations
Review Sep 2026

NRF2-Regulated Ferroptosis in Breast Cancer: Mechanisms, Resistance, and Therapeutic Opportunities.

The molecular mechanisms by which NRF2 regulates ferroptosis, including KEAP1-NRF2 signaling, metabolic rewiring, iron homeostasis, lipid remodeling, and crosstalk with p53 and other stress-response pathways are summarized.

S. Mohammad, A. Vasudevan, Samreet Raizal Rodrigues et al. · 0 citations
Review Aug 2026

AEG-1/MTDH: A central regulator of tumor progression, metabolic adaptation, and therapeutic resistance in gliomas.

Gen silencing studies demonstrate that AEG-1 knockdown reduces proliferation, promotes apoptosis, and enhances sensitivity to chemotherapeutic agents such as cisplatin, doxorubicin, and temozolomide, and support its potential as a target for combinatorial therapeutic strategies to improve outcomes in aggressive brain a...

S. Mohammad, A. Vasudevan, M. Al-Khreisat et al. · 0 citations
Review Open access Sep 2026

Decellularized extracellular matrix bioinks through a polymer engineering lens: tissue-source-dependent macromolecular architecture, crosslinking chemistry, rheological behavior, and 3D bioprinting performance.

A polymer engineering perspective provides a more mechanistically useful basis for dECM bioink design than biological fidelity alone, and matching tissue-specific matrix composition, crosslinking architecture, rheological behavior, and printing parameters is essential for advancing dECM-based constructs toward clinical...

Y. Q. Almajidi, Ho Soonmin, Mirza R. Baig et al. · 0 citations
Review Sep 2026

Extracellular Vesicles in Neurodegenerative Diseases: A New Frontier in Diagnosis and Therapy.

The biogenesis, classification, isolation methods, and molecular content of EVs are reviewed, and their role in the pathogenesis, diagnosis, and treatment of the most important neurodegenerative diseases is analyzed.

S. Mohammad, A. Vasudevan, G. Oriquat et al. · 0 citations
Meta-analysis Open access Aug 2026

Comprehensive in silico genomics analysis of global trends and host-specific emergence of aminoglycoside resistance in Staphylococcus aureus: a One-Health perspective

The global resistome is mapped to map the global resistome, quantify temporal and host-specific trends, and assess the association between genetic determinants and phenotypic resistance by analyzing over 110,000 S. aureus genomes.

Amr A. El-Sehrawy, S. Jasim, Haneen Fadhil Jasim et al. · 0 citations
Review Open access Sep 2026

Regulatory roles of pyroptosis-associated lncRnas in breast cancer progression and immune microenvironment.

Clinical translation remains limited by dependence on retrospective transcriptomic datasets, insufficient mechanistic validation, lack of standardized assays, and scarce prospective clinical evidence, but pyroptosis-associated lncRNAs represent a promising link between tumor progression and immune regulation, with cons...

Chou-Yi Hsu, Bilal Abdulmajeed Mukhlif, O. Nematov et al. · 0 citations
Review Open access Aug 2026

Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes

Challenges such as scalable production, cargo heterogeneity, and regulatory considerations remain, but ongoing advances in exosome engineering and patient-derived vesicles are poised to overcome these barriers.

Amr Ali Mohamed Abdelgawwad El-Sehrawy, Hassan Youssef Hussein, O. Nematov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.